MB
Therapeutic Areas
Iris Medicine Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Huntington’s Disease Program | Huntington’s Disease | Preclinical |
| C9orf72 ALS Program | C9orf72 Amyotrophic Lateral Sclerosis | Preclinical |
| Spinocerebellar Ataxias Program | Spinocerebellar Ataxias | Preclinical |